Acute liver injury and Acute liver failure
- Page Path
-
- HOME
- TOPICS
- Acute liver injury and Acute liver failure
- Correspondence
- Correspondence to editorial on “Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment”
- Do Seon Song, Dong Joon Kim
- Clin Mol Hepatol. 2024;30(4):1012-1015. Published online June 18, 2024
-
View: 1646 Download: 23
- Editorial
- Modified quick-SOFA score: Can it enhance prognostic assessment for hospitalized patients with chronic liver diseases?: Editorial on “Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment”
- Simone Incicco, Salvatore Piano
- Clin Mol Hepatol. 2024;30(4):695-697. Published online June 3, 2024
-
View: 1902 Download: 38 Web of Science: 1 Crossref: 1
- Review
- Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia-reperfusion injury
- Jia Liu, Ranyi Luo, Yinhao Zhang, Xiaojiaoyang Li
- Clin Mol Hepatol. 2024;30(4):585-619. Published online July 1, 2024
-
View: 4370 Download: 338 Web of Science: 9 Crossref: 12
- Original Article
- Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment
- Do Seon Song, Hee Yeon Kim, Young Kul Jung, Tae Hyung Kim, Hyung Joon Yim, Eileen L Yoon, Ki Tae Suk, Jeong-ju Yoo, Sang Gyune Kim, Moon Young Kim, Young Chang, Soung Won Jeong, Jae Young Jang, Sung-Eun Kim, Jung-Hee Kim, Jung Gil Park, Won Kim, Jin Mo Yang, Dong Joon Kim, Korean Acute-on-Chronic Liver Failure (KACLiF) study group, Ashok Kumar Choudhury, Vinod Arora, Shiv Kumar Sarin, APASL ACLF Research Consortium (AARC) for APASL ACLF working party
- Clin Mol Hepatol. 2024;30(3):388-405. Published online April 11, 2024
-
View: 3759 Download: 130 Web of Science: 4 Crossref: 4
- Review
- Acute-on-chronic liver failure: Terminology, mechanisms and management
- Vinay Kumar BR, Shiv Kumar Sarin
- Clin Mol Hepatol. 2023;29(3):670-689. Published online March 20, 2023
-
View: 10734 Download: 935 Web of Science: 33 Crossref: 41
- Original Article
- Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding
- Jongbeom Shin, Jung Hwan Yu, Young-Joo Jin, Hyung Joon Yim, Young Kul Jung, Jin Mo Yang, Do Seon Song, Young Seok Kim, Sang Gyune Kim, Dong Joon Kim, Ki Tae Suk, Eileen L. Yoon, Sang Soo Lee, Chang Wook Kim, Hee Yeon Kim, Jae Young Jang, Soung Won Jeong, on Behalf of the Korean Acute-onChronic Liver Failure (KACLiF) Study Group
- Clin Mol Hepatol. 2020;26(4):540-553. Published online September 17, 2020
-
View: 8264 Download: 214 Web of Science: 24 Crossref: 24
- Editorial
- Acute-on-chronic liver failure: A predictor of poor prognosis in patients with variceal bleeding or a risk factor for variceal bleeding?
- Nae-Yun Heo
- Clin Mol Hepatol. 2020;26(4):487-488. Published online October 1, 2020
-
View: 5062 Download: 120 Web of Science: 2 Crossref: 2
- Review
- The fibrogenic process and the unleashing of acute-on-chronic liver failure
- Guillermo Nahúm López-Sánchez, Mayra Dóminguez-Pérez, Misael Uribe, Natalia Nuño-Lámbarri
- Clin Mol Hepatol. 2020;26(1):7-15. Published online June 14, 2019
-
View: 13394 Download: 376 Web of Science: 10 Crossref: 11
- Acute-on-chronic liver failure
- Tae Yeob Kim, Dong Joon Kim
- Clin Mol Hepatol. 2013;19(4):349-359. Published online December 28, 2013
-
View: 14688 Download: 254 Crossref: 46
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
Video abstract
-
- Interventions targeting the gut-liver axis: A potential treatment strategy for metabolic dysfunction-associated steatotic liver disease
- Modulation of lymphatic vessels in management of liver disease and complications
- Metabolic dysfunction-associated steatotic liver disease across women’s reproductive lifespan and issues
- Examining the therapeutic landscape of beta-blockers in portal hypertension
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor16.9First decision
07 Days
Publication after acceptance
04 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2023-2025)
|
|||||||
